Cinryze Injection, Powder, Lyophilized, For Solution
Product Images NDC 42227-081

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Cinryze (NDC 42227-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Cinryze 01)

An instructional illustration showing hands preparing a medication vial by inserting a small vial or container labeled 'STERILE WATER' into a larger vial labeled 'CINRYZE'. The image demonstrates the initial step of adding sterile water to the medication vial, likely for reconstitution purposes.*

FDA Label Image

Figure 2 (Cinryze 02)

An instructional illustration depicting hands preparing a vial, with one hand holding a small bottle and the other hand holding a larger vial labeled 'Sterile Water.' The image likely demonstrates the process of mixing or reconstituting a medication using sterile water.*

FDA Label Image

Figure 3 (Cinryze 03)

An instructional line drawing showing a step in medication preparation for Cinryze 500 IU/5mL kit. The image depicts hands connecting a vial labeled 'Sterile Water' to another vial labeled 'Cinryze,' illustrating vial attachment for reconstitution prior to administration.*

FDA Label Image

Figure 4 (Cinryze 04)

An instructional line drawing showing the preparation of an intravenous medication kit. The image depicts a hand holding a Cinryze vial while connecting it to a vial labeled as sterile water or diluent, illustrating the mixing or reconstitution step for the intravenous infusion of Cinryze human C1-esterase inhibitor 500 IU/5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure 5 (Cinryze 05)

An instructional illustration showing the assembly process of a liquid medication vial and a diluent vial. The hands demonstrate connecting the two vials by aligning and twisting them together, likely for reconstitution or mixing of the medication before administration.*

FDA Label Image

Figure 6 (Cinryze 06)

An instructional illustration showing hands holding a vial labeled Cinryze and a second vial labeled Sterile Water for Injection. Arrows indicate the removal of caps from the tops of the vials, depicting the initial step in preparing the Cinryze kit for use.*

FDA Label Image

Figure 7 (Cinryze 07)

An instructional illustration showing two steps of preparing the Cinryze kit. The first image depicts a hand holding a bottle labeled Cinryze and removing its cap. The second image shows a hand holding a bottle labeled Sterile Water, also removing its cap. Both images demonstrate how to open the bottles prior to mixing or administration.*

FDA Label Image

Figure 8 (Cinryze 08)

An instructional diagram showing hands demonstrating the removal or handling of a small vial or cartridge, likely related to the Cinryze 500 IU/5 mL plasma derivative kit by Takeda Pharmaceuticals America, Inc. The image illustrates a step in the product's preparation or use process.*

FDA Label Image

Figure 9 (Cinryze 09)

An instructional line drawing showing the preparation of an injection or infusion kit. A vial labeled 'Sterile Water' is held by one hand, and another hand is removing a stopper or cap from a smaller vial positioned above the water vial, indicating the process of mixing or reconstitution. This likely corresponds to the Cinryze 500 iU/5mL kit for intravenous use.*

FDA Label Image

Figure 10 (Cinryze 10)

An instructional illustration showing hands performing a procedure involving a vial labeled 'WATER' and a second container. One hand holds the vial steady while the other hand is positioning a stopper or cap onto the vial. The image appears to depict part of the preparation process for a medication kit.*

FDA Label Image

Figure 11 (Cinryze 11)

An instructional illustration showing the assembly of two vial components. The upper vial, labeled with the text 'WATER FOR INJECTION,' is being lowered and connected to the bottom vial, which is held by another hand. This diagram likely demonstrates the preparation steps for reconstituting a medication from separate vials.*

FDA Label Image

Figure 12 (Cinryze 12)

An instructional line drawing showing a person assembling or preparing a Cinryze vial kit. The illustration depicts hands holding and connecting components of the kit, demonstrating proper attachment and usage steps.*

FDA Label Image

Figure 13 (Cinryze 13)

An instructional line drawing showing a hand holding a Cinryze vial while a sterile water vial is inverted above it, illustrating the preparation of the Cinryze kit by adding sterile water to the Cinryze vial.*

FDA Label Image

Figure 14 (Cinryze 14)

An instructional illustration depicting the process of attaching a vial adapter to a vial labeled 'Cinryze.' The image shows one hand holding the vial and another hand twisting the adapter to connect it securely. The arrows indicate the direction to align and twist the adapter for proper attachment.*

FDA Label Image

Figure 15 (Cinryze 15)

An instructional illustration showing hands drawing liquid into a syringe from a vial or ampule, demonstrating preparation steps likely relevant to administering a pharmaceutical product such as Cinryze human C1-esterase inhibitor kit.*

FDA Label Image

Figure 16 (Cinryze 16)

An instructional illustration showing a person handling a vial labeled 'Cinryze.' The image depicts the steps for attaching a syringe to the vial, including holding the vial steady and twisting the syringe onto the vial's stopper.*

FDA Label Image

Figure 17 (Cinryze 17)

An instructional line drawing showing two hands preparing an injection. One hand is holding a vial labeled with an obscured name, while the other hand inserts a syringe needle into the vial, likely for withdrawal of medication. The illustration likely demonstrates medication preparation steps for a product such as Cinryze 500 iU/5mL KIT.*

FDA Label Image

Figure 18 (Cinryze 18)

An instructional line drawing showing a person's hands preparing an injection using a vial and syringe. The image depicts the process of drawing a liquid from the vial into the syringe, likely related to the reconstitution or administration of Cinryze, a HUMAN C1-ESTERASE INHIBITOR plasma derivative kit.*

FDA Label Image

Figure 19 (Cinryze 19)

An instructional line drawing showing hands holding and preparing a syringe, likely depicting how to withdraw or administer medication from a vial or similar container, without any visible text or labeling.*

FDA Label Image

Figure 20 (Cinryze 20)

An instructional line drawing showing a hand holding a vial and using a syringe to draw liquid from the vial, demonstrating medication preparation technique.*

FDA Label Image

Figure 21 (Cinryze 21)

An instructional illustration showing a close-up of two hands holding a syringe. The illustration depicts the action of pulling the plunger back to draw liquid into the syringe barrel, suggesting preparation of an injection.*

FDA Label Image

Figure 22 (Cinryze 22)

An instructional illustration depicting a hand holding a vial and a syringe, demonstrating the preparation or drawing of medication from the vial into the syringe. This image likely relates to the usage or administration instructions of a pharmaceutical product kit.*

FDA Label Image

Figure 23 (Cinryze 23)

An instructional illustration depicting the preparation of a liquid medication kit. The image shows a hand holding a vial labeled for the product and a syringe being inserted into the vial for withdrawal of the medication.*

FDA Label Image

Figure 24 (Cinryze 24)

An instructional illustration showing a hand holding a syringe while another hand is peeling back a protective cap from a needle, demonstrating preparation for an injection.*

FDA Label Image

Figure 25 (Cinryze 25)

An instructional illustration showing a person applying pressure or checking the inner side of their forearm with one hand. The drawing is a simple black-and-white line art with no additional text or labels.*

FDA Label Image

Figure 26 (Cinryze 26)

An instructional line drawing showing a person holding an intravenous (IV) line connected to the arm of another person, illustrating the setup or administration of an intravenous infusion. The image depicts the arm with a vein accessible for IV insertion and a hand holding tubing connected to an IV bag.*

FDA Label Image

Figure 27 (Cinryze 27)

An instructional illustration showing the proper technique for locating a vein on the arm, likely for intravenous access or injection. The image depicts a person’s arm with a finger pressing to identify a vein in the crook of the elbow area.*

FDA Label Image

Principal Display Panel (500 U Vial Label)

Label for Cinryze 500 IU, a human C1-esterase inhibitor for intravenous injection available as a single-dose vial kit. The label includes reconstitution instructions with 5 mL sterile water, a use timeline of within 3 hours after reconstitution, and manufacturer information by ViroPharma Biologics LLC, Lexington, MA.*

FDA Label Image

Principal Display Panel (500 U Vial Carton)

Packaging label for Cinryze 500 IU, human C1 esterase inhibitor, plasma derivative kit for intravenous injection. The label details storing conditions, reconstitution instructions, and manufacturer information, including ViroPharma Biologics LLC. Contains 1 single-dose vial and is for prescription use only.*

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for a 5 mL vial of Sterile Water for Injection, USP, intended for reconstitution of an accompanying product. The label includes handling instructions, manufacturer Takeda Pharmaceuticals America, Inc., and indicates a single-dose, nonpyrogenic container. No antimicrobial agents are added.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Cinryze 500 IU human C1 esterase inhibitor plasma derivative kit by Takeda Pharmaceuticals America, Inc. The label states it is for intravenous injection and includes storage instructions and product composition details. The label features a purple and orange color scheme with barcodes and manufacturer information from ViroPharma Biologics LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.